行情

BDX

BDX

碧迪
NYSE

实时行情|Nasdaq Last Sale

261.95
-0.72
-0.27%
盘后: 261.95 0 0.00% 16:54 09/17 EDT
开盘
262.00
昨收
262.67
最高
262.93
最低
260.41
成交量
288.77万
成交额
--
52周最高
267.37
52周最低
219.50
市值
752.29亿
市盈率(TTM)
41.14
分时
5日
1月
3月
1年
5年
网络安全在 MedTech 中的地位日益突出:值得关注的 3 只股票
Zacks.com · 2天前
更新:支持替代手术业务的 1.42 亿美元 PIPE 交易包括来自 Becton Dickinson 和 New Frontier Health Corporation 的战略投资
The total $142 million PIPE supporting the transaction is funded by multiple strategic investors including global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), major hospital groups
Benzinga · 4天前
批准替代手术业务组合;股票将于 9 月 20 日开始在纽约证券交易所交易为“RBOT”
Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)))), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical
Benzinga · 4天前
北美和欧洲氧气治疗市场- 2028 年趋势、类型、应用和机会展望展望
Research Nester has released a report titled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market s...
AmericaNewsHour · 4天前
经皮冠状动脉介入治疗市场——2027 年预测的新兴技术、趋势、行业增长、细分市场、景观和需求
Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market sh...
AmericaNewsHour · 5天前
ASYMmetric ETFs Trust 收购 Jack Henry & Associates Inc、Cabot Oil & Gas Corp、Tyler ...
GuruFocus News · 6天前
为什么拜登的行动计划看好 COVID-19 测试股票
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 million rapid point of care and at-home COVID-19 tests.
Benzinga · 09/10 15:56
Vicarious Surgical Inc. 和 D8 Holdings Corp. 宣布额外的 PIPE 承诺
Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE: DEH), a speci...
Business Wire · 09/10 00:34
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解BDX最新的财务预测,通过BDX每股收益,每股净资产,每股现金流等数据分析碧迪近期的经营情况,然后做出明智的投资选择。
分析师评级

18位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测BDX价格均价为267.80,最高价位285.00,最低价为250.00。
EPS
机构持股
总机构数: 1,955
机构持股: 2.68亿
持股比例: 93.23%
总股本: 2.87亿
类型机构数股数
增持
544
1,337.52万
建仓
90
207.17万
减持
562
1,180.11万
平仓
115
243.42万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-0.10%
医疗设备和用品
+0.65%
高管信息
Chairman/President/Chief Executive Officer/Chief Operating Officer/Director
Thomas Polen
Chief Financial Officer/Executive Vice President
Christopher DelOrefice
Corporate Executive
David Hickey
Chief Human Resource Officer/Executive Vice President/Director of Human Resources
Betty Larson
Executive Vice President/Chief Administrative Officer
Christopher Reidy
Executive Vice President
Simon Campion
Executive Vice President
Alexandre Conroy
Executive Vice President
Roland Goette
Executive Vice President
Samrat Khichi
Executive Vice President
James Lim
Executive Vice President
Alberto Mas
Chief Accounting Officer/Vice President/Controller
Thomas Spoerel
Lead Director/Independent Director
Marshall Larsen
Independent Director
Catherine Burzik
Independent Director
R. Andrew Eckert
Independent Director
Claire Fraser
Independent Director
Jeffrey Henderson
Independent Director
Christopher Jones
Independent Director
David Melcher
Independent Director
Claire Pomeroy
Independent Director
Rebecca Rimel
Independent Director
Timothy Ring
Independent Director
Bertram Scott
公告日期
每股分红
除权日期
2021/07/27
每股分红:USD 0.83
2021/09/08
2021/04/27
每股分红:USD 0.83
2021/06/08
2021/01/25
每股分红:USD 0.83
2021/03/09
2020/11/24
每股分红:USD 0.83
2020/12/09
2020/07/27
每股分红:USD 0.79
2020/09/08
2020/04/28
每股分红:USD 0.79
2020/06/08
2020/01/27
每股分红:USD 0.79
2020/03/09
2019/11/25
每股分红:USD 0.79
2019/12/09
2019/07/22
每股分红:USD 0.77
2019/09/06
2019/04/29
每股分红:USD 0.77
2019/06/06
2019/01/21
每股分红:USD 0.77
2019/03/07
2018/11/19
每股分红:USD 0.77
2018/12/07
2018/07/24
每股分红:USD 0.75
2018/09/06
2018/04/23
每股分红:USD 0.75
2018/06/07
2018/01/23
每股分红:USD 0.75
2018/03/08
2017/11/21
每股分红:USD 0.75
2017/12/07
2017/07/27
每股分红:USD 0.73
2017/09/07
2017/05/24
每股分红:USD 0.73
2017/06/07
2017/01/24
每股分红:USD 0.73
2017/03/08
2016/11/22
每股分红:USD 0.73
2016/12/07
BDX 简况
Becton, Dickinson and Company(BD)是一家从事医疗用品及设备、实验设备和诊断产品的开发、制造及销售业务的全球医疗技术公司。该公司通过BD医疗部门、BD生命科学部门和BD介入性部门运营。BD医疗部门生产一系列医疗技术和设备,用于帮助改善各种环境中的医疗保健服务。BD医疗部门由多个业务部门组成,包括药物递送解决方案、药物管理解决方案、糖尿病护理和制药系统。BD生命科学部门提供用于安全收集和运输诊断标本的产品,以及用于检测一系列传染病、医疗保健相关感染和癌症的仪器和试剂系统。BD介入部门提供血管、泌尿科、肿瘤科和外科专业产品。

微牛提供Becton Dickinson and Co(NYSE-BDX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的BDX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BDX股票基本功能。